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Chikungunya virus (CHIKV) is a re-emerging arbovirus responsible for a massive outbreak currently afflicting the Indian
Ocean region and India. Infection from CHIKV typically induces a mild disease in humans, characterized by fever,
myalgia, arthralgia, and rash. Cases of severe CHIKV infection involving the central nervous system (CNS) have recently
been described in neonates as well as in adults with underlying conditions. The pathophysiology of CHIKV infection
and the basis for disease severity are unknown. To address these critical issues, we have developed an animal model of
CHIKV infection. We show here that whereas wild type (WT) adult mice are resistant to CHIKV infection, WT mouse
neonates are susceptible and neonatal disease severity is age-dependent. Adult mice with a partially (IFN-a/bR
þ/ )o r
totally (IFN-a/bR
 / ) abrogated type-I IFN pathway develop a mild or severe infection, respectively. In mice with a mild
infection, after a burst of viral replication in the liver, CHIKV primarily targets muscle, joint, and skin fibroblasts, a cell
and tissue tropism similar to that observed in biopsy samples of CHIKV-infected humans. In case of severe infections,
CHIKV also disseminates to other tissues including the CNS, where it specifically targets the choroid plexuses and the
leptomeninges. Together, these data indicate that CHIKV-associated symptoms match viral tissue and cell tropisms,
and demonstrate that the fibroblast is a predominant target cell of CHIKV. These data also identify the neonatal phase
and inefficient type-I IFN signaling as risk factors for severe CHIKV-associated disease. The development of a
permissive small animal model will expedite the testing of future vaccines and therapeutic candidates.
Citation: Couderc T, Chre ´tien F, Schilte C, Disson O, Brigitte M, et al. (2008) A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk
factors for severe disease. PLoS Pathog 4(2): e29. doi:10.1371/journal.ppat.0040029
Introduction
Chikungunya virus (CHIKV) was ﬁrst isolated in Tanzania
in 1953 [1], and has recently emerged in islands of the Indian
Ocean in 2005, and engendered the largest Chikungunya
fever epidemic on record [2]. The most affected region was
the island of La Re ´union, where CHIKV infected approx-
imately a third of the island’s inhabitants (i.e., ;300,000) [3–
5]. The outbreak, which now also involves India with an
estimated 1.3 million cases [6–8], has a signiﬁcant potential to
spread globally given the wide distribution of its arthropod
vector [9,10].
CHIKV is a member of the genus Alphavirus in the family of
Togaviridae. Alphaviruses are small, enveloped viruses with a
message-sense RNA genome that encodes four non-structural
proteins (nsP1–4) and three structural proteins (C, E1–2).
This arbovirus is maintained in nature by uninterrupted
cycles of transmission between mosquitoes and vertebrate
hosts such as macaques [11–13]. Several alphaviruses cause
disease in humans, primarily as a result of epizootic
infections. These include the American encephalitic alphavi-
ruses and several species in the Semliki Forest Virus group,
principally the Afro-Asian CHIKV, the African O’Nyong-
Nyong virus, as well as the Australasian Barmah Forest virus
and Ross River virus [14]. CHIKV infection is characterized by
fever, arthralgia, myalgia, rash and headache. During the La
Re ´union Island outbreak, previously unreported severe forms
of Chikungunya infection were observed in adults, compli-
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severe cases almost exclusively occurred in adults with
underlying conditions such as diabetes, alcoholic hepatop-
athy or impaired renal function [3,15]. Moreover, while
CHIKV-associated fatalities had not been reported prior to
this outbreak, at least 213 persons infected with CHIKV died
in La Re ´union Island [16,17]. Finally, although never
described before, per-partum mother-to-child CHIKV trans-
mission has been observed and is associated with severe
neonatal disease characterized in more than half of the cases
by encephalopathy [18,19].
The pathophysiology of human CHIKV infection has so far
remained essentially unknown, in part because of the lack of a
permissive small animal model. In order to gain a better
understanding of CHIKV-associated pathophysiology, we
have developed a mouse model of infection. Using this model
system and comparing it to human samples, we have
uncovered the following pathophysiological features of
CHIKV infection: (i) viral dissemination and disease severity
are strongly increased during the neonatal period, (ii) type-I
IFN signalling plays a critical role in the control of the
infection and is associated with severe infection when
deﬁcient, (iii) symptomatic organs are those infected by
CHIKV, and (iv) ﬁbroblasts of connective tissues are
prominent cell targets in vivo, in permissive mice as well as
in humans. Together, this study offers the ﬁrst in depth in
vivo analysis of CHIKV cellular tropism and offers a validated
small animal model that may prove useful for the develop-
ment and testing of novel vaccine and therapeutic strategies.
Results
Neonatal Mice Are Permissive to CHIKV Infection
In order to study the pathophysiology of CHIKV infection
in the adult and neonatal hosts, we aimed to develop a small
animal model of infection. We ﬁrst inoculated a series of
classical laboratory mouse strains: outbred OF1 mice and
inbred C57BL/6 and 129s/v mice. Intra-dermal (ID) injection
of 10
6 PFU of CHIKV-21, isolated from an individual from La
Reunion with central nervous system (CNS) symptoms [4],
showed that WT adult OF1 C57BL/6 and 129s/v mice are
resistant to CHIKV infection. Neither morbidity nor mortal-
ity was observed following infection and no infectious virus
could be recovered from tissues (unpublished data). In
contrast, neonatal C57BL/6 mice exhibited an age-dependent
lethality to CHIKV infection (Figure 1A): six-day-old and 9-
day-old mice all developed ﬂaccid paralysis on D6 or D7 post
infection (pi), and all 6-day-old mice died before D12 pi,
whereas more than half of 9-day-old infected mice recovered.
Strikingly, by day 12 of life, C57BL/6 mice showed neither
morbidity nor mortality following infection. We investigated
the kinetic of virus replication in tissues of 9-day-old mice at
D3 and D5 pi and at the onset of symptoms (D7 pi). Infectious
virus was detected at low level at D3 pi in serum and at D5
and D7 pi in liver (Figure 1B). Strikingly, at all time points
analyzed, infectious CHIKV was detected very abundantly in
Figure 1. CHIKV Infection in Mouse Neonates
(A) Survival of mouse neonates according to their age. Mouse neonates
were inoculated with 10
6 PFU of CHIKV via the ID route and observed for
lethality (n¼6 per group). (B) Viral titers in tissues of 9-day-old neonates.
Mice were inoculated with 10
6 PFU of CHIKV via the ID route and
sacrificed at the indicated time points. The amount of infectious virus in
serum and tissues were quantified by TCID50. Each data point represents
the arithmetic mean 6 SD for at least four mice. The broken line
indicates the detection threshold.
doi:10.1371/journal.ppat.0040029.g001
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Author Summary
Chikungunya virus (CHIKV) is transmitted by mosquito bites. CHIKV
has recently re-emerged and is responsible for a massive outbreak in
the Indian Ocean region and India. It has also reached Italy,
indicating that CHIKV has a great potential to spread globally.
Infection from CHIKV typically induces a mild disease in humans,
characterized by a flu-like syndrome associated with muscle and
joint pain and rash. Cases of severe infection involving the central
nervous system (CNS) have recently been described, notably in
neonates. We have developed the first animal model for CHIKV
infection and studied the pathophysiology of the resulting disease.
We show here that mouse neonates are susceptible to CHIKV and
neonatal disease severity is age-dependent. Adult mice with a partial
or complete defect in type-I interferon pathway develop a mild or
severe infection, respectively. In mice with a mild infection, CHIKV
primarily targets muscle, joint and skin fibroblasts, a cell and tissue
tropism similar to that observed in biopsy samples of CHIKV-infected
humans. In case of severe infections, CHIKV also disseminates to the
CNS. Our work indicates that CHIKV-associated symptoms perfectly
match viral tissue and cell tropisms, and demonstrate that the
fibroblast is a prominent target cell of CHIKV. It also identifies the
neonatal phase and inefficient type-I interferon signaling as risk
factors for severe CHIKV-associated disease. The development of a
permissive small animal model will expedite the testing of future
vaccines and therapeutic candidates.muscle, joint and skin and to a lower extent in the brain
(Figure 1B).
Together, these results establish that, as observed in
humans, CHIKV pathogenicity is strongly age-dependent in
mice, and that in less-than 12 day-old mouse neonates,
CHIKV induces a severe disease. Of note, in the infected
neonatal mice, CHIKV is abundantly detected in the same
organs than those symptomatic in humans, particularly
infected neonates and babies under the age of one year [18].
IFN-a/bR
þ/  and IFN-a/bR
 /  Animals Provide In Vivo
Models for Mild and Severe Forms of CHIKV Infection,
Respectively
That neonatal mice but not adult mice were permissive to
CHIKV infection ruled out the existence of an intractable
species barrier in the mouse. It also questioned the nature of
mouse adult non-permissiveness. Guided by the well-estab-
lished ability of CHIKV and other alphaviruses to trigger
type-I IFN synthesis and their sensitivity to type-I IFN
responses [20–24], we tested the permissiveness of adult
IFN-a/bR knockout (IFN-a/bR
 / ) mice towards CHIKV.
In contrast to WT adult mice, all infected IFN-a/bR
 /  adult
mice developed a severe disease characterized by muscle
weakness of the limbs (i.e., loss of muscle tone) and lethargy
and died at D3 pi (Figure 2A). Whereas no mortality was
observedinWTadultmice inoculatedwith10
6PFUofCHIKV-
21, the lethal dose 50 (LD50) was of 3 PFU in adult IFN-a/bR
 / 
adult mice, with an average survival of 3 6 0.2 days. Similar
results were obtained when infecting IFN-a/bR
 /  adult mice
with two other isolates from La Re ´union (CHIKV-27 and 115)
and one African isolate from Congo (CHIKV-117) (unpub-
lished data). Together, these results indicated that the basis for
the resistance of WT adult mice to CHIKV is linked to type-I
IFN signalling, which thus stands as a key player in the control
of CHIKV infection.
We next investigated CHIKV replication in tissues of WT
and IFN-a/bR
 /  adult mice inoculated via the ID route. As
IFNAR-a/bR
 /  adult mice are highly susceptible to CHIKV
infection, we inoculated them with about 10 LD50, i.e., 20
PFU, whereas we inoculated WT mice with 10
6 PFU, and
determined the viral load in mouse tissues at different time
points pi. CHIKV was not isolated from tissues of WT mice at
H3, H16, H32, D3 pi, or D6 pi (Figure 2B and unpublished
data). In IFN-a/bR
 /  mice at H16 pi, infectious virus was
detected only in the liver. At D3 pi, it was abundantly
detected in muscles, joints, skin, and brain with high viral
titers also present in serum, liver and spleen (Figure 2B).
Similar results were obtained with the Congolese isolate
CHIKV-117 (unpublished data).
In search for a model of non-lethal CHIKV infection that
would reﬂect the mild disease predominantly observed in
human adults, we evaluated disease pathogenesis in IFN-a/
Figure 2. CHIKV Infection in Mice According to the Integrity of the IFNa/
b Pathway
(A) Survival of mice inoculated with 10
6 PFU of CHIKV via the ID route (n
¼6 for each category). (B) Viral titers in IFN-a/bR
 / , IFN-a/bR
þ/ , and WT
adult mice infected via the ID route with 20, 10
6, and 10
6 PFU,
respectively. At the indicated time points, mice were sacrificed and the
amount of infectious virus present in serum and tissues was quantified
by TCID50. Each data point represents the arithmetic mean 6 SD for at
least four mice. A broken line indicates the detection threshold.
doi:10.1371/journal.ppat.0040029.g002
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þ/  adult mice. In IFN-a/bR
þ/  adult mice –which express
IFN-a/bR to a similar level found in WT animals, as assessed
by FACS analysis (unpublished data)–, no mortality nor
lethargy was observed upon infection with 10
6 PFU of CHIK-
21 (Figure 2A). However, in contrast to what was observed in
WT adult mice, infectious virus was recovered from liver as
early as H16, at titers similar to that of IFN-a/bR
 /  infected
mice (Figure 2B). Strikingly, at D3 pi, infectious virus was
conﬁned to muscles and joints (Figure 2B) after which the
virus was cleared and reached undetectable levels by D6 pi
(unpublished data). These data suggest that a dose effect of
type-I IFN receptor gene controls the level of permissiveness
of adult mice towards CHIKV, with IFN-a/bR
þ/  and IFN-a/
bR
 /  adult mice developing a mild and severe infection,
respectively. As observed in human clinical cases, the mild
form of the disease corresponds to a peripheral infection
targeting predominantly skeletal muscles and joints, whereas
the severe form is also associated with viral dissemination to
other organs, including the CNS.
CHIKV Cell Tropism in Mice
We next investigated the cell tropism of CHIKV in liver at
H16 pi and in peripheral infected tissues, namely, liver,
skeletal muscles, joints and skin at D3 pi. In liver of infected
adult IFN-a/bR
 /  mice at H16 pi, a weak labelling of CHIKV
antigens was detected in sinusoidal capillary endothelial cells
(Figure S1A–S1C), as well as in some F4/80 labelled mature
macrophages (Figure S1D–S1F), whereas at D3 pi, consistent
with a sharp increase in liver and serum viral loads, CHIKV
immunolabeling was more intense and diffuse, and co-
localized within and around sinusoid capillaries (Figure
S1G–S1I). Conﬁrmatory ﬁndings were obtained by trans-
mission electron microscopy analysis of sections from the
same infected livers. These images reveal numerous CHIKV
particles budding at the surface of sinusoid capillary
endothelial cells (Figure S2A). A lower number of viral
particles were also found associated with (arrow) or budding
at the surface (arrowhead) of Kupffer cells (Figure S2B). In
order to further investigate viral replication in this cell type,
we isolated primary liver macrophages and infected them in
vitro. Although only low levels of viral replication were
observed, we do conclude that liver macrophages are capable
of being infected by CHIKV (Figure S1J). In contrast, brain-
derived microglial cells were refractory to infection suggest-
ing that macrophages are not a general target of infection
(Figure S1J). In spleen, the immunolabelling for viral antigen
was exclusively observed in the red pulp, notably in F4/80-
positive cells (unpublished data).
In skeletal muscles of infected adult IFN-a/bR
 /  mice, and
to a lower intensity of IFN-a/bR
þ/  mice, CHIKV immuno-
labelling was predominantly observed in connective tissue,
particularly in the external region, the epimysium (also called
muscle fascia), and to a lower extent in the perimysium and
endomysium (Figure 3A–3C). Consistent with these observa-
tions, viral load was higher in the epimysium than in the
perimysium/endomysium (unpublished data). The main target
cells in muscles were ﬁbroblasts, as shown by the morphology
of the cells and their co-immunolabelling with anti-vimentin
and anti-CHIKV antibodies (Figure S3), and the absence of
basal lamina surrounding the immunolabeled cells (Figure
3A–3C). Few immunolabeled F4/80-positive macrophages
were also observed in the epimysium and to a lesser extent
in the perimysium where they predominated around middle
size arteries and veins in a close contact with ﬁbroblasts
(unpublished data). Consistent with a recent study performed
on human material [25], rare satellite cells were also
immunolabeled (arrowhead in Figure 3B), readily recogniz-
able as small mononucleated cells located beneath the muscle
ﬁber basal lamina. In skeletal muscles, myoﬁbers were not
immunolabelled with anti-CHIKV antibodies.
In IFN-a/bR
 /  adult mice at D3 pi, ﬁbroblasts of the joint
connective tissue located beneath the synovial wall were also
infected (Figure 3F–3H), but both deep articular and osseous
tissues (i.e., chondrocytes and osteocytes and osteoblasts)
were uninfected. In the skin, viral antigens were also observed
in ﬁbroblasts of the deep dermis (Figure 3D, 3E). In IFN-a/
bR
þ/  adult mice at D3 pi, viral antigens were also detected in
ﬁbroblasts of the connective tissue of joints (Figure 3I) and
skin (unpublished data) but to a lower level than in IFN-a/
bR
 /  mice.
Viral cell tropism in infected peripheral tissues of neo-
nates, including muscle, joint and skin was similar to that of
adult mice, with a pronounced tropism for ﬁbroblasts (Figure
4A–4C). A notable difference was the presence of severe
necrotic myositis consistent with severe myoﬁber necrosis
and inﬂammation manifested by the inﬁltration of lympho-
cytes and monocytes/macrophages (Figure 4D, 4E). Impor-
tantly, our in vitro experiments with primary mouse and
human muscle ﬁbroblasts conﬁrm the high permissiveness of
this cell type towards CHIKV (unpublished data).
To investigate whether blood leukocytes were a target for
CHIKV in vivo, peripheral blood mononucleated cells from
infected IFN-a/bR
 /  mice obtained in the course of the
infection (D1 to D3 pi) were double-stained with an anti-
CHIKV and a pan-murine haematopoietic cell marker
(CD45.2 antibody) and analyzed by ﬂow cytometry. No
infected leukocyte was detectable in the blood of infected
mice, indicating that blood leukocytes do not represent a
signiﬁcant cell target for CHIKV in vivo (unpublished data),
as also reported in the in vitro context [26].
Together, these data show that in infected peripheral
tissues of adult IFN-a/bR
þ/ and IFN-a/bR
 / mice, as well as in
WT neonates, ﬁbroblasts constitute a prominent target cell of
CHIKV.
CHIKV Dissemination to the CNS
We next investigated the histopathology and CHIKV
infection of the CNS. The only histopathological ﬁnding in
IFN-a/bR
 /  mice at the CNS level was a severe vacuolization
of choroid plexus epithelial cells and often of the adjacent
ependymocytes (Figure 5A). Choroid plexuses, ependymal
wall, and lepto-meningeal cells, including external cells in the
Virchow-Robin spaces, were strongly stained for CHIKV,
whereas the brain parenchyma did not show signiﬁcant
labelling (Figure 6). We could observe no CHIKV immuno-
labelling in microglial cells and astrocytes, including those
forming the glia limitans (unpublished data). The choroid
plexuses, which form the blood-cerebrospinal ﬂuid (CSF)
barrier, were infected (Figure 6D). In contrast, microvascular
endothelial cells that constitute the blood-brain barrier (BBB)
were not (Figure 6A, arrowheads). Viral titer in the meninges
of infected IFN-a/bR
 /  was 5-fold higher than in the total
brain (Figure 5B). In the CNS of infected WT mouse neonates,
CHIKV infection was also detected at the leptomeningeal
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the brain parenchyma.
To determine whether CHIKV infection altered the
permeability of the BBB, we administrated intravenously
horseradish peroxydase (HRP), which does not diffuse to the
brain parenchyma when the BBB is intact, but leaks into the
brain parenchyma in case of BBB disruption [27]. HRP in
brains of infected IFN-a/bR
 /  adult mice, was conﬁned to the
lumen of brain microvessels, as observed in the brains of
mock-infected mice (Figure 5C). Thus, despite a strong
infection of the meninges and of the Virchow-Robin spaces,
the barrier function of the brain microvessels was preserved
upon infection.
These in vivo ﬁndings were conﬁrmed in in vitro BBB
systems [28,29]. Primary choroid plexus epithelial cells were
highly susceptible to infection via the apical route (Figure 7A)
and to a lesser extent via the basal route (Figure 7B),
suggesting that CHIKV accesses the cerebrospinal ﬂuid
through the choroid plexuses, and may also secondarily
infect choroid plexus epithelial cells via their apical surface,
thus amplifying viral titers in the CSF. In sharp contrast,
primary brain microvessel endothelial cells were fully
resistant to CHIKV infection (Figure 7C). Together, these
ﬁndings suggest that CHIKV gets access to the CNS via the
choroid plexuses, and exhibit a marked tropism for the
meninges, whereas it does not infect the brain microvessels
and parenchyma and does not induce tissue alteration at the
brain parenchyma level.
CHIKV Maternal-Fetal Infection
Given the observations made during the La Re ´union
outbreak that CHIKV can be vertically transmitted from
Figure 3. CHIKV Cell and Tissue Tropisms in Mice
IFN-a/bR
 /  mice ID inoculated with 20 PFU and IFN-a/bR
þ/  ID inoculated with 10
6 PFU route were sacrificed at D3 pi. Multiple immunostaining were
performed on tissue cryosections from IFN-a/bR
 /  mice (A to G) and from IFN-a/bR
þ/  mouse (I), and transmission electron microscopy on joint from
IFN-a/bR
 /  mice (H). Nuclei stained by Hoechst appear in blue, CHIKV in red (A to G and I). Basal lamina (collagen IV) (A to D) and mesenchymal cells
(vimentin) (I9) appear in green. In all these pictures bar is 10 lm. Muscle fibroblasts, identified notably as cells not surrounded by a basal lamina, display
a strong immunostaining for CHIKV in the epimysium (arrow) and endomysium (arrowhead) of skeletal muscle (A). Fibroblasts (arrows) and very few
satellite cells (arrowhead) easily recognizable as a single mononucleated cell located beneath the muscle fiber basal lamina are labeled for CHIKV
antigens in endomysium of skeletal muscle (B and C). Fibroblasts were also immunostained for CHIKV in deep dermis (D and E) and in joint capsule (F
and G). (H) Transmission electron microcopy view of viral particles (arrow in H and H9) in contact and within the cytoplasm of a cell in connective tissue,
identified as a fibroblast because of the absence of surrounding basal lamina and the adjacent type I collagen fibers. Infected cells positive for CHIKV in
skeletal muscle of IFN-a/bR
þ/  mouse (I), identified as fibroblasts since they were not surrounded by basal lamina and expressed vimentin (I9).
doi:10.1371/journal.ppat.0040029.g003
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A Mouse Model for Chikungunyaviremic mothers to their newborns, we investigated maternal-
fetal transmission of CHIKV in pregnant IFN-a/bR
 /  mice
infected with CHIKV-21 via the ID route at D16–18 of
gestation. At D2 pi, animals were sacriﬁced and viral titers
determined in maternal serum as well as in placentas and
fetuses (Figure 8A). As expected, viral load in maternal serum
was elevated. In contrast, placenta viral titers were at least 2
orders of magnitude lower and fetuses were uninfected
(Figure 8A). Moreover, no CHIKV immunolabeling could be
observed in these placentas (unpublished data). The non-
permissiveness of the placental barrier towards CHIKV was
conﬁrmed in vitro, by the observation that the human
syncytiototrophoblastic cell line BeWo is refractory to
infection (Figure 8B).
CHIKV Tissue and Cell Tropisms in Humans
In order to test the relevance for human of our in vivo and
in vitro studies, we investigated CHIKV cell and tissue
tropisms in biopsy samples of CHIKV-infected humans with
acute CHIKV infection. We developed a sensitive and speciﬁc
immunohistochemistry assay (see Materials and Methods) to
detect CHIKV antigens in available human tissue samples
from a fatal neonatal case. In the tissues that are the classical
sites of symptoms in the human disease, namely the skeletal
muscles, joints and skin, CHIKV antigens were detected, and
viral infection appeared to be conﬁned to ﬁbroblasts of the
joint capsule, of skeletal muscle fascia and of the dermis
(Figure 9A–9C). As brain human samples were not available,
we could not investigate CHIKV dissemination to the CNS.
However, studies in experimentally infected Cynomolgus
monkey, who develop a severe CHIKV infection, indicate
that CHIKV disseminates to the CNS, where it targets the
choroid plexus and the leptomeninges, but not the brain
microvessels and parenchyma (Roques et al. personal com-
munication).
Together, these results demonstrate that in humans,
CHIKV is present in symptomatic organs, and that the
ﬁbroblast is the privileged cell target in these organs.
Moreover, and in agreement with the frequent positivity of
CHIKV RT-PCR in the CSF of humans with CNS symptoms
[30], CHIKV is able to reach the CNS via the choroid plexuses
and preferentially target the leptomeninges in Cynomolgous
monkey.
Discussion
Here we have combined in vivo, in vitro, and histopathol-
ogy approaches to gain a better insight in Chikungunya
disease pathophysiology. Using the mouse as a model, we
show that in the neonatal host, as well as in adult mice
harboring one or two copies of IFN-a/bR null allele, CHIKV
exhibits a marked tropism for skeletal muscles, joints and
skin, which constitute the classical symptomatic organs in the
human disease. This shows that, in contrast to other acute
viral infections in which symptoms may predominantly
reﬂect the systemic immune response rather than viral organ
dissemination (e.g., inﬂuenza), classical symptoms of Chikun-
gunya disease closely reﬂect CHIKV tissue tropism. Indeed,
our study provides direct evidence that in the mouse adult
and neonate models, as well as in humans, muscles, joints and
skin are privileged CHIKV targets.
We demonstrate here that CHIKV infection severity is
critically dependent on two host factors: age and function-
ality of type-I IFN signaling, thus underlining similarities
Figure 4. CHIKV Cell and Tissue Tropisms in Mouse Neonates
Nine-day old IFN-a/bR
þ/þmice were infected with 10
6 PFU of CHIKV by ID route. Overlay image (A) of infected muscle connective tissue immunolabeled
for vimentin (B) and CHIKV (C). Hematoxylin and eosin staining (D) of longitudinal section of skeletal muscle shows a severe necrotizing myositis with
numerous infiltrates and necrosis of the muscle fibers. Immunostaining of CHIKV antigens (red) and nuclei (blue) on muscle (E) and brain (F) sections.
Note that the endomysium displays a strong CHIKV immunolabeling, as well as leptomeningeal cells. Bar is 10lm.
doi:10.1371/journal.ppat.0040029.g004
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[23,31]. In the neonatal host as well as in the adult mouse
with a totally abrogated type-I IFN signaling, CHIKV-
associated disease is particularly severe, and this severity
correlates with higher viral loads and dissemination to the
CNS. Importantly, similar ﬁndings have been reported in
human neonates and adults with severe disease [32]. The
reasons why the neonatal status and a defect in type-I IFN
signaling favor severe CHIKV infection may partly overlap,
but speciﬁc neonatal factors may also be involved. Indeed, a
number of physiological variables differentiate the neonatal
and adult hosts, including the relative proportion of tissue
ﬁbroblasts, the rate of cell division, and the maturity and
effectiveness of the innate immune system [33]. Future work
will have to focus on the similarities and differences between
the neonatal and adult hosts with respect to type-I IFN
triggering, signaling and responses. Nevertheless, the basic
characteristics of CHIKV cell and tissue tropisms are
conserved in these two complementary models, and their
similarity with what observed in humans strongly argues in
favor of their pathophysiological relevance.
With the IFN-a/bR
þ/  mice, we also provide a model for the
benign CHIKV human infection. This animal model should
prove very helpful in the development of future vaccine and
therapeutic strategies. Importantly, that the gene copy
number of IFN-a/bR strictly inﬂuences the viral load and
tissue distribution as well as the severity of the disease is a
strong indication that the strength of type-I IFN signaling
likely plays a critical role in the control of CHIKV replication.
The signiﬁcance of CHIKV speciﬁc tissue tropism is
emphasized by the observation that tissue ﬁbroblasts con-
stitute the principal CHIKV cell target in all these infected
peripheral organs. This in vivo ﬁnding is consistent with the
in vitro observation that primary mouse muscle ﬁbroblasts
are susceptible to CHIKV infection (unpublished data) as well
the recent ﬁnding by Sourrisseau and colleagues that cultured
human lung and mouse skin ﬁbroblasts are permissive to
CHIKV [26]. The molecular basis for this prominent in vivo
tropism for ﬁbroblasts is unknown and may indicate that
ﬁbroblasts could be, relative to other cell types, either (i) in a
hyper-permissive status towards CHIKV entry/replication,
and/or (ii) in a hypo-sensitive status to type-I IFN-mediated
viral interference, making them a target of choice for CHIKV.
Interestingly, it is proposed that ﬁbroblasts of connective
tissue of dermis, joint capsules [34–36], and muscles have in
common the property to form a reticular network of cells
interconnected by gap junctions. Whether this characteristic
contributes to the selective in vivo hyper-susceptibility of
connective ﬁbroblasts to CHIKV infection, and if it plays a
role in viral cell-to-cell dissemination deserves future inves-
tigations.
Of note, similarly to CHIKV in mouse neonates, Ross River
virus, an alphavirus closely related to CHIKV and associated
with muscle and joint pathology, has been shown to induce
myositis in adult mice [23,37,38]. The absence of myositis in
CHIKV-infected IFN-a/bR
 /  adult mice could be linked to
their early lethality, while it could be linked to the rapid
recovery of CHIKV-infected IFN-a/bR
þ/  adult mice.
Before reaching its target organs, CHIKV undergoes an
early burst of viral replication in the liver in IFN-a/bR
þ/  and
IFN-a/bR
 /  mice. Indeed, in these mice, the liver is the ﬁrst
and only detectably infected tissue until H32 pi, and CHIKV
antigens are primarily detected in sinusoidal capillary
endothelial cells and to a lesser extent in Kupffer cells. By
D3 pi, and only in IFN-a/bR
 /  mice, there is a sharp increase
in viremia, with CHIKV antigen detectable in the red pulp of
the spleen. This is in contrast with what has been observed
with Sindbis virus infection, in which a high level of infection
is detected in the spleen of IFN-a/bR
 /  mice as early as D1 pi
with a subsequent dissemination to the liver at D2 pi
[23,37,38]. In the spleen as in the liver, macrophage-dendritic
like cells are thought to be the main target cells of Sindbis
virus, although by D3 pi in the liver, ‘‘sinusoid-lining cells’’
Figure 5. CHIKV Targets the Choroid Plexus and Meningeal Tissue but
Does Not Affect the BBB Permeability in IFN-a/bR
 /  Mice
Mice were infected with 20 PFU of CHIKV via the ID route and sacrificed
at D3 pi. (A) Hematoxylin and eosin staining of brain shows a severe
vacuolization of epithelial cells of the choroid plexuses (B) The amount of
infectious virus present in isolated meninges and in the total brain was
quantified by TCID50. Each data point represents the arithmetic mean 6
SD for at least three mice (* p , 0.05). (C) Representative brain sections
of both infected and mock-infected mice after intravenous injection of
type VI HRP showing the integrity of the BBB by the absence of any
leakage of the staining that remains sequestrated into blood vessels. As a
positive control is shown the HRP leakage (arrowhead) induced by the
neurotropic yeast Cryptococcus neoformans, which is known to disrupt
the BBB integrity.
doi:10.1371/journal.ppat.0040029.g005
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infected [23]. These in vivo differences between Sindbis (and
other alphaviruses such as SFV, EEV or Ross River virus) and
CHIKV could reﬂect the non-permissiveness of dendritic cells
to CHIKV (unpublished data and [26]). We also found that, in
contrast to mouse liver macrophages, CHIKV is not detected
in mouse blood leukocytes in vivo. These data are consistent
with previous experiments that showed that human primary
monocytes are not permissive to CHIKV, whereas human
primary macrophages are [26].
Earlier studies on Sindbis and Ross River also identiﬁed the
connective tissues of joints and skeletal muscles as sites of
viral replication, although the cell type targeted by these
viruses in these tissues has not been formally identiﬁed
[23,37,38]. We show here that this connective tissue tropism
also extends to CHIKV. It is thus likely that these shared
tropisms and symptoms highlight a common viral pathogenic
property, the understanding of which should provide critical
clues to the pathophysiologic properties of alphaviruses
responsible for arthralgia. Interestingly, both joint and
muscle connective tissues contain a high amount of nocicep-
tive nerve-endings [39] that may account for the muscle and
joint pain characterizing disease caused by alphaviruses
associated with muscle and joint pathology.
In the case of severe CHIKV infection, we found that
CHIKV disseminates to the CNS, as also observed in human
[30] and non-human primates (Roques et al. personal
communication). It is noteworthy that all CHIKV isolates
tested exhibited a similar ability to reach the CNS. CHIKV
dissemination to the CNS does not correspond to non-speciﬁc
spreading due to an overwhelming viral multiplication.
Indeed, CHIKV is not detected at the brain microvessel and
parenchyma levels, but gets access the CNS exclusively via the
choroid plexus route, and undergoes a step of viral
ampliﬁcation at the ependyma and leptomeningeal levels. In
agreement with these ﬁndings, CHIKV is detected in the CSF
in humans with severe human Chikungunya disease associated
with CNS symptoms [30]. Thus, in contrast to what has been
observed for American encephalitic alphaviruses, CHIKV
does not appear to be intrinsically encephalitogenic and is
associated with reversible CNS symptoms in humans, in line
with a virus that does not invade the brain parenchyma nor
Figure 6. CHIKV Cell and Tissue Tropisms in the Mouse CNS
IFN-a/bR
 /  mice inoculated via the ID route with 20 PFU were sacrificed at D3 pi and immunostaining was performed on brain cryosections. Nuclei
appear in blue and CHIKV in red. Basal lamina (collagen IV) is stained in purple (A) or green (B), and astrocytes and glia limitans (GFAP) appear in green
(A and C). Leptomeningeal cells (arrows) display a strong immunolabeling for CHIKV while brain microvessells (arrowheads) and glial cells do not (A).
Virchow-Robin spaces showed immunostaining for CHIKV (B) as well as ependymal cells (C) and choroid plexuses (D). Bar is 10 lm.
doi:10.1371/journal.ppat.0040029.g006
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endothelium and is not detectable at the brain parenchyma
level also contrasts with what has been observed with the more
closely related Semliki Forest virus, which targets the brain
microvessels and also infects neurons [40,41]. Leptomeningeal
tissues are, like ﬁbroblasts, of mesenchymatous origin, and
exhibits common features with peripheral ﬁbroblastic con-
nective tissue capsules, as they also play a common ‘‘envelop’’
function and form an interconnected multicellular network
that acts as a regulatory interface between cerebrospinal ﬂuid
and the surface of the brain and between arterioles within the
brain and the surrounding neural tissue (Virchow-Robin
spaces) [42]. These common tissue organizations and func-
tions may play a role in CHIKV dissemination.
Given its public health and pathophysiological importance,
we also investigated CHIKV infection in the pregnant host.
By use of the most permissive model we have developed, the
Figure 7. In Vitro Susceptibility of Cells Constituting the BBB
Primary cells were infected with CHIKV at a MOI of 10 then viral antigens
were detected by immunofluorescence. Apical (A) and basal (B) infection
of epithelial cells from choroid plexuses for 18 h. Note the lesser number
of immunofluorescent cells following basal infection compared to apical
infection. Endothelial cells from brain microvessel were infected for 48 h
but viral antigens were not detected (C).
doi:10.1371/journal.ppat.0040029.g007
Figure 8. CHIKV Infection in Pregnant IFN-a/bR
 / Mice and Resistance of
Human Syncytiotrophoblast Cells to CHIKV
(A) Pregnant mice were infected with 20 PFU of CHIKV via the ID route
between 16 and 18 d of gestation. Two days later, viral titers were
determined in serum and liver, as well as in placentas and fetuses (four
mothers, from three to six fetuses per mother). The broken line indicates
the detection threshold. (B) The human syncytiototrophoblastic cell line
BeWo, and human foreskin fibroblasts HFF as a positive control, were
infected with CHIKV at a MOI of 10, and viral load in the culture medium
was titrated at the indicated time point by TCID50. Each data point
represents the arithmetic mean 6 SD for at least four independent
experiments.
doi:10.1371/journal.ppat.0040029.g008
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 /  mice, we show that the placenta does not
constitute a privileged target for CHIKV. Indeed, no infected
cells can be detected when observing placental tissue sections
from infected mice. This is in line with our investigations
carried out in human placentas obtained from viremic
mothers, in which no infected cell could be detected by
mean of immunohistochemistry either [18]. This suggests that
viral titers detected in mouse and human placentas rather
correspond to a contamination from remaining maternal
serum than to an actual placental infection. This is supported
by our in vitro ﬁnding that human syncytiotrophoblast is
refractory to infection, and by the observation that ante-
partum fetal contamination is exceptional in humans [18].
This provides an explanation for why all cases of vertical
transmission of CHIKV in the recent outbreak in La Re ´union
were observed in per-partum, at a time when highly viremic
maternal blood can get in contact with the fetal circulation,
particularly in the setting of the uterine contractions of the
labor, which are known to induce placental barrier breaches.
These observations appear to contrast with what observed
with Ross River virus, for which actual placental infection and
transplacental dissemination have been described both in
mice and humans [43,44].
In conclusion, we have developed a mouse animal model
for CHIKV infection, allowing us to uncover the viral tissue
and cell tropism of this re-emerging alphavirus. We have
shown that, in this model, as well as in humans, the ﬁbroblast
is the cell type chieﬂy targeted by CHIKV, and that this
accounts for its tropism for muscles, joint and skin
connective tissues. The molecular basis for this tropism is
currently unknown but may combine speciﬁc virus-host cell
and tissue interactions as well as an intrinsic relatively lower
ability of this cell type to control CHIKV infection. We have
also identiﬁed two critical factors inﬂuencing viral replica-
tion, which are the neonatal status, and a defective type-I IFN
signaling. Whereas it is clear that an increased neonatal
susceptibility is also observed in humans, the relevance of
type-I IFN defect as a basis for severe infection in humans
remains to be demonstrated. However, the fact that severe
infections in humans are exclusively observed in individuals
with underlying conditions renders this hypothesis attractive
[3,15]. This may indicate that type-I IFN could be of interest
to prevent severe disease in adults, as well as in exposed
neonates. In addition, the use of neutralizing antibodies also
appears interesting, given the strong correlation between
viral load and disease severity. A better understanding of the
pathophysiology of CHIKV infection and the ensuing devel-
opment of therapeutic strategies are both critical in the
context of a possible globalization of the current CHIKV
epidemic.
Materials and Methods
Virus. CHIKV isolates were obtained from individuals during the
2005–06 CHIKV outbreak in La Re ´union Island and ampliﬁed on
mosquito C6/36 cell as described [4]. CHIKV-21 was isolated from the
serum of a newborn male with CHIKV-associated encephalopathy;
CHIKV-27 was isolated from the CSF of another new-born male with
encephalopathy; CHIKV-115 from the serum of a 24-year old female
with classical CHIK symptoms. CHIKV-117 was isolated at the Institut
de Me ´decine Tropicale du Service de Sante ´ des Arme ´es (IMTSSA),
Marseille, France during the 2000 CHIKV outbreak in Democratic
Republic of the Congo from the serum of a person presenting
classical CHIK symptoms. Titers of virus stocks were determined by
standard Vero cell plaque assay and are expressed as PFU per ml.
Cells. Primary choroid plexuses and brain microvascular endothe-
lial cells were obtained, puriﬁed and cultured as described [28,29].
The Bewo cell line was obtained from the ATCC. Cells were infected
with CHIKV at a multiplicity of infection (MOI) of 10.
Human tissue. Human tissue samples were obtained from biopsy
specimens collected in the course of the clinical care of people with
CHIKV infection in La Re ´union.
Animals. Outbred OF1 mice, and inbred C57BL/6 and 129s/v mice
were obtained from Charles River laboratories (France). IFN-a/bR
 / 
129s/v mice were given by F. Tangy with permission from M. Aguet
[45]. Mice were bred according to the Institut Pasteur guidelines for
animal husbandries and were kept in level-3 isolators. Mice were
inoculated by ID in the ventral thorax with 50 ll of a viral suspension
diluted with PBS for adult mice and with 30 ll for neonates. Mock-
infected mice received PBS alone. Mice were anesthetized with
isoﬂurane (Forene, Abbott Laboratories Ltd, United-Kingdom).
Blood was collected by cardiac puncture after which each mouse
was perfused via the intracardiac route with 40 ml of PBS at 4 8C
before harvesting of organs. Tissues were homogenized, and virus
titers of each tissue sample determined on Vero cells by tissue
cytopathic infectious dose 50 (TCID50), and viral titers in tissues and
in serum were expressed as TCID50/g or TCID50/ml, respectively. The
principles of good laboratory animal care were followed all through
the experimental process. Pregnant female IFN-a/bR
 / mice at 16–18
days of gestation were infected with 20 PFU of CHIKV via the ID
route. At D2 pi, maternal serum, placentas and fetuses were
harvested, and viral titers determined in each sample. Mortality
studies were performed on groups of six mice and viral titers in
tissues from four mice at each time point.
Histology and immunoﬂuorescence. Mouse organs were snap
frozen in isopentane cooled by liquid nitrogen for cryosectionning
or ﬁxed in para-formaldehyde for parafﬁn embedding. Parafﬁn-
embedded tissues were processed for histological staining (Hema-
toxylin and eosin). For immunoﬂuorescence, cryosections were ﬁxed
for 10 min in ice-cold methanol before incubation for 12 h at 4 8C
with the primary antibodies followed by incubation for 1 h with the
Figure 9. CHIKV Immunolabeling in Human Tissue Samples
In human tissues, viral antigens were detected in fibroblasts of dermis (A), of epimysium of skeletal muscle (B) and of joint capsule (C). Bar is 10lm.
doi:10.1371/journal.ppat.0040029.g009
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A Mouse Model for Chikungunyasecondary antibodies. Slides were counterstaining with Hoechst
(Vector Lab). The following antibodies were used: polyclonal rabbit
anti-collagen IV (Chemicon, Temecula CA, 1:200), polyclonal chicken
anti-vimentin (Abcam, Cambridge, UK, 1:200), monoclonal mouse
anti-GFAP (BD pharmingen 1:1,000 or 1:5,000 to only see the glia
limitans), monoclonal rat anti-macrophage antigen F4/80 (Abcam,
1:100), polyclonal rabbit anti-PECAM1/CD31 (Abcam, 1:400), human
serum anti-CHIKV were obtained and characterized by the Centre
National de Re ´fe ´rence des Arbovirus as positive for anti-CHIKV IgM
and IgG. The marker speciﬁcities were systematically conﬁrmed by
examining sections in which the primary antibody was replaced by
control isotype or immunoglobulins at the same concentration and
by immunostaining of non-infected tissues from the same animal
strain. Slides were examined with a Zeiss AxioPlan 2 microscope
equipped with an ApoTome system in order to obtain 0.7 lm thick
optical sections. Pictures and Z-stacks were obtained using the
AxioVision 4.5 software. When necessary, images were processed
using the image J software (http://rsb.info.nih.gov/ij/).
Electron microscopy. Ultra thins sections were observed at 80 kV
accelerating voltage using a JEOL JEM 1010 Electron Microscope.
Chromogenic immunohistochemistry. Chromogenic immunohis-
tochemistry was performed on human tissues. After antigen
unmasking (97 8C, 20 min), a monoclonal antibody against CHIKV
(provided by bioMe ´rieux and the IMTSSA, France) was incubated
overnight and revealed with a polymer detection kit (SuperPicTuree
Zymed, http://www.invitrogen.com/) and the DAB chromogen (Vector
Lab, http://www.vectorlabs.com/).
Evaluation of BBB leakage. BBB permeability was studied using I.V.
injection of type VI HRP (Sigma) (30 mg/ml dissolved in Evans blue
2% in 0.9% saline to provide 100 mg/kg) as previously described
[27,46]. Five brains were studied for CHIKV-infected mice as well as
for mock-infected mice.
IFN-a/bR expression analysis. Mouse splenocytes were isolated,
labeled with biotinylated goat anti-mouse IFN-a/bR1 antibody
(BFA3039, R&D systems), incubated with streptavidin-APC and
analyzed by ﬂow cytometry.
Supporting Information
Figure S1. CHIKV Detection in Liver of IFN-a/bR
 /  Mice at H16 pi
and D3 pi
CHIKV antigens appear in red, CD31 positive cells and F4/80 positive
cells in green. At H16 pi, CHIKV antigens were detected in sinusoidal
capillary endothelial cells (CD31 positive) (A–C), and in liver
macrophages (F4/80 positive) (D–F). At D3 pi, CHIKV antigens were
detected within and around sinusoidal capillaries (G–I). (J) Suscept-
ibility of FACS-sorted mouse liver macrophages and microglia to
CHIKV. Primary cells were infected with CHIKV at a MOI of 10 then
and viral load in the culture medium was titrated at the indicated
time point by TCID50. Each data point represents the arithmetic
mean 6 SD for at least four independent experiments. A broken line
indicates the detection threshold.
Found at doi:10.1371/journal.ppat.0040029.sg001 (3.7 MB TIF).
Figure S2. Transmission Electron Microscopy of Liver Sections from
CHIKV-Infected IFN-a/bR
 /  Mice at D3 pi
On the right pictures are shown enlargement of the boxed regions on
the left pictures. Bar is 2 lm on the left and 1 lm on the right. Viral
particles are budding (arrowhead) and associated with the plasma
membrane (arrow) of sinusoidal capillary endothelial cells (A,A9) and
Kupffer cells (B,B9).
Found at doi:10.1371/journal.ppat.0040029.sg002 (2.6 MB TIF).
Figure S3. CHIKV Target Cells in Muscle are Fibroblasts
Immunostaining was performed on skeletal cryosections from
CHIKV-infected IFN-a/bR
 /  mice. Nuclei were stained by DAPI
(blue), CHIKV was detected using a human serum anti-CHIK (red),
and mesenchymal cells were stained with rabbit polyclonal antibodies
against vimentin (green). Cells of perimysium stained for viral
antigens were also labeled with vimentin, indicating they are
ﬁbroblasts. Bar is 10 lm.
Found at doi:10.1371/journal.ppat.0040029.sg003 (1.0 MB TIF).
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